Nureca · NSE: NURECA · BSE: 543264

Q4 FY24 results · Jan–Mar 2024

Nureca reported revenue from operations of ₹16.97 crore (down 20.1% from Q4 FY23) and net loss of ₹4.15 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations16.9721.23−20.1%22.37−24.2%
Other income(1.26)2.15Turned loss5.90Turned loss
Total income15.7123.37−32.8%28.27−44.4%
Profit before tax(6.47)(1.97)Loss widened0.94Turned loss
Net profit for the period(4.15)(1.53)Loss widened0.17Turned loss
EPS, basic (₹)(4.15)(1.53)Loss widened0.16Turned loss
Net margin (%)-24.4-7.20.7
Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations19.5621.22−7.8%22.37−12.6%
Other income(1.25)2.15Turned loss5.92Turned loss
Total income18.3123.37−21.6%28.30−35.3%
Profit before tax(6.74)(2.30)Loss widened0.83Turned loss
Net profit for the period(4.41)(1.80)Loss widened0.08Turned loss
EPS, basic (₹)(4.41)(1.80)Loss widened0.08Turned loss
Net margin (%)-22.6-8.50.3
Consolidated
Filed with BSE
17 May 2024, 16:07 IST
Board meeting
15 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
17 May 2024, 16:07 IST
Board meeting
15 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE